Vestor Capital’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
VCM
N
Vestor Capital's REGN Position: Q1 2026 in Review
Vestor Capital increased its Regeneron Pharmaceuticals (REGN) stake by 482% in Q1 2026, buying an estimated $7.39M and bringing the position to 11,655 shares worth $9.01M. The position accounts for 0.65% of the portfolio, ranked #47.
Vestor Capital first reported a position in REGN in Q2 2023 and has held it in 3 quarters since. The position peaked at $9.01M in Q4 2025. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.
- Vestor Capital held 11,655 shares of Regeneron Pharmaceuticals worth $9.01M as of Q1 2026.
- Vestor Capital bought 9,654 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $7.39M.
- Regeneron Pharmaceuticals made up 0.65% of Vestor Capital's portfolio in Q1 2026, its #47 holding.
- Vestor Capital first reported a position in Regeneron Pharmaceuticals in Q2 2023 and has held it in 3 quarters since.
- Vestor Capital's Regeneron Pharmaceuticals position peaked at $9.01M in Q4 2025.
- 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.
Based on Vestor Capital's 13F filing for Q1 2026, filed 21 May 2026.